Direxion Daily S&P Biotech Bull 3x Shares (LABU) Holdings $70.30 -0.01 (-0.01%) Closing price 04:10 PM EasternExtended Trading$69.98 -0.31 (-0.45%) As of 06:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Top 25 LABU HoldingsRankCompanyCurrent PriceWeightShares Held1S&P Biotechnology Select Industry Index SwapN/A18.37%205,3802Dreyfus Govt Cash Man InsN/A12.65%98,161,7333Goldman Sachs Sterling FixInc Port IncN/A11.31%87,755,3354Goldman Sachs Fin Gov 465 InstitutN/A9.18%71,229,4225Dreyfus Trsry Securities Cash MgmtN/A2.85%22,131,9556ALNYAlnylam Pharmaceuticals$451.50-0.6%2.15%37,1247INSMInsmed$134.72+0.1%1.86%113,1118INCYIncyte$83.77-1.3%1.80%160,9919HALOHalozyme Therapeutics$72.57-0.8%1.78%205,84410UTHRUnited Therapeutics$306.17+0.3%1.62%40,090 Get the Latest News and Ratings for LABU and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and its competitors with MarketBeat's FREE daily newsletter. 11REGNRegeneron Pharmaceuticals$578.30-1.5%1.60%21,38712GILDGilead Sciences$112.39-1.3%1.55%101,41213ABBVAbbVie$207.66-0.2%1.54%57,89014NBIXNeurocrine Biosciences$138.38+0.2%1.53%89,26815BBIOBridgeBio Pharma$52.19+5.2%1.50%226,89916BIIBBiogen$132.90-2.5%1.49%83,30517AMGNAmgen$285.66-0.8%1.45%37,98218BMRNBioMarin Pharmaceutical$57.55-1.9%1.44%193,90819MRNAModerna$24.35-3.0%1.44%399,41820NTRANatera$167.13+2.5%1.40%66,45721MDGLMadrigal Pharmaceuticals$434.65+2.3%1.35%28,28622EXELExelixis$37.88-1.6%1.32%267,54123VRTXVertex Pharmaceuticals$390.77+0.4%1.24%24,49624EXASExact Sciences$47.16+1.0%1.17%199,13025ROIVRoivant Sciences$11.93-0.5%1.04%681,297 Geographic ExposureUnited States59.8%Bermuda1.1%Switzerland0.9%Ireland0.7%Virgin Islands, British0.3%Currency ExposureUSD321.8%Sector ExposureHealth Care62.1%Consumer Discretionary0.7%Biotechnology0.2%Energy0.1%Industry ExposureBiotechnology58.6%Health Care Equipment & Supplies2.3%Health Care Providers & Services1.4%Distributors0.6%Renewable Energy0.1%Diversified Consumer Services0.1%SubIndustry ExposureBiotechnology58.7%Life Sciences Tools & Services2.1%Health Care Services1.4%Pharmaceuticals0.5%Health Care Equipment0.1%Renewable Energy Equipment0.1%Health Care Supplies0.1%Coupon Exposure4-640.2%Maturity Exposure20-30219.4% Related Companies and Tools Related Companies PPH Holdings IHE Holdings RSPH Holdings IHF Holdings FXH Holdings BBH Holdings RYH Holdings PJP Holdings PBE Holdings FBT Holdings This page (NYSEARCA:LABU) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bull 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bull 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access